KRAS and NRAS genes mutations as biomarkers in the therapy of colorectal cancer and the basic methods of their detection
Determination of the mutations' status in the KRAS and NRAS genes is a necessary requirement in the treatment of patients with colorectal cancer (CRC). Patients with certain mutations in the KRAS and NRAS genes are resistant to anti-EGFR drug therapy and have a lower median survival rate than t...
Enregistré dans:
Auteurs principaux: | Olga I. Brovkina, Alexey G. Nikitin |
---|---|
Format: | article |
Langue: | RU |
Publié: |
Eco-vector
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f188be48a67348c79d1798ffd8d2b72d |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Associations of Polymorphisms Localized in the 3′UTR Regions of the <i>KRAS</i>, <i>NRAS</i>, <i>MAPK1</i> Genes with Laryngeal Squamous Cell Carcinoma
par: Ruta Insodaite, et autres
Publié: (2021) -
CRISPR and KRAS: a match yet to be made
par: Guzide Bender, et autres
Publié: (2021) -
Intracellular nanoparticle delivery by oncogenic KRAS-mediated macropinocytosis
par: Liu X, et autres
Publié: (2019) -
Analysis of KRAS Mutation Subtype in Tissue DNA and Cell-Free DNA Using Droplet Digital PCR and the Function of Cell-Free DNA as a Recurrence Predictive Marker in Pancreatic Cancer
par: Eunsung Jun, et autres
Publié: (2021) -
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer
par: Gongmin Zhu, et autres
Publié: (2021)